USPTO serial 88627487
PLYNRESCA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 22, 2023
- Examiner
- YOUNG, CARRIE SKYE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PLYNRESCA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
BeyondSpring Pharmaceuticals, Inc.
New York, NY
Other trademarks owned by BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc.
New York, NY
Other trademarks owned by BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc.
New York, NY
Other trademarks owned by BeyondSpring Pharmaceuticals, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ian W. Gillies
Ian W. Gillies KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET14TH FLOORIRVINE, CA 92614Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and preparations for the prevention and treatment of cancer and side-effects from cancer therapy; pharmaceutical products and preparations for the prevention and treatment of neutropenia | ACTIVE | — |
| 042 | Providing scientific information and medical research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; providing scientific research and medical research information via the internet; pharmaceutical research and development services; research and development of new products; medical and scientific research in the fields of biochemistry, biotechnology, and clinical trials | ACTIVE | — |
| 044 | Providing medical information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; providing medical information via the internet | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BeyondSpring Pharmaceuticals, Inc.
- Other trademarks owned by BeyondSpring Pharmaceuticals, Inc.
- Other trademarks owned by BeyondSpring Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PLYNRESCA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 22, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 22, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 16, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 3, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 29, 2023 | IUAF | USE AMENDMENT FILED | — |
| Jun 29, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 22, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 21, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 21, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 8, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 8, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 21, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 17, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 17, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 17, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 23, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 21, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 21, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 21, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 3, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 1, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 1, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 1, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 7, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 7, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 7, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 7, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 12, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 31, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2019 | NWAP | NEW APPLICATION ENTERED | — |